Product Description
The global orthopedic cartilage repair market was valued at $405 million in 2024. This is expected to increase over the forecast period at a CAGR of 9.2% to reach $750 million.
The full report suite on the global market for orthopedic cartilage repair includes osteochondral allografts, meniscal allografts, autologous chondrocytes and osteochondral autograft.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ORTHPEDIC CARTILAGE REPAIR MARKET INSIGHTS
One of the main market limiters remains to be the high cost of the procedure. The high cost of the procedure is out of the budgetary range of many potential patients, even for some with private insurance. This cost is not expected to decline significantly over the forecast period and will continue to limit the number of units sold.
GLOBAL ORTHPEDIC CARTILAGE REPAIR MARKET SHARE INSIGHTS
- Vericel was the leader in the cartilage repair market due to its offering of MACI®, an autologous cartilage repair therapy for knee defects. The treatment involves expanding a patient’s own cartilage cells on a collagen membrane for implantation. In August 2024, the FDA approved an arthroscopic delivery method, allowing for less invasive procedures and faster recovery.
- Octane Medical Group, the second-leading company in the cartilage repair market, expanded its regenerative medicine portfolio by acquiring B. Braun’s global orthobiologics business, including TETEC AG and Aesculap Biologics. Through this acquisition, Octane Medical strengthened its position by offering NOVOCART® 3D, a matrix-associated autologous chondrocyte implantation (ACI) system using a collagen scaffold for knee cartilage repair, and NOVOCART® Inject, an injectable hydrogel-based cartilage repair solution. These additions enhance Octane’s capabilities in advanced orthobiologic treatments, further solidifying its market presence.
- Arthrex was the third-leading competitor in the cartilage repair market in 2024. The company provides various cartilage repair solutions, including Allograft OATS®, Autograft OATS®, BioCartilage® and Cartiform®, which are used for resurfacing osteochondral defects. The PowerPick system facilitates microdrilling for microfracture procedures, and the joint preservation algorithm offers treatment options for different defect sizes. These products are designed to support joint preservation and cartilage repair.
GLOBAL ORTHPEDIC CARTILAGE REPAIR MARKET SEGMENTATION SUMMARY
- Osteochondral Allograft Market
- Meniscal Allograft Market
- Autologous Chondrocyte Implantation Market
- Osteochondral Autograft Market
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |